Advanced Enzyme Technologies Ltd Share Price

Pharmaceuticals

NSE: ADVENZYMES Small Cap ISIN: INE837H01020

As on 13 June 2026 at 01:08 IST

₹369.25

+ 7.85

(2.17%)

Sell Buy

Over 1 Month

-7.43%

Over 6 Months

18.20%

Over 1 Year

8.61%

Over 3 Years

32.11%

Advanced Enzyme Technologies Ltd Summary

Close ₹361.40

Open ₹362

High ₹369.10

Low ₹358.10

Volume 97,361

Net Turnover (in Cr) ₹3.53

52Wk High ₹419

52Wk Low ₹251.95

52Wk High / Low

251.95

419

Advanced Enzyme Technologies Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹4,046.82

EPS (TTM) 12.06

Book Value (BV) 63.37

Div. Yield 0.37 %

P/E (TTM) 30.73

Price/Book Value 5.71

Delivery % 43.59 %

Face Value 2

Key Ratios

PE Ratio 30.48

PB Ratio 4.96

EV to Sales 8.87

PEG Ratio -5.67

ROA 16.18

ROE 16.93

Debt-Equity -

Net Profit Margin 29.15

Operating Profit Margin 37.69

Advanced Enzyme Technologies Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	669.95	660.53	566.09	535.80	510.69
Total Expenses	482.59	457.58	421.64	364.75	300.32
Profit Before Tax	187.36	187.82	140.39	171.06	210.37
Profit After Tax	133.97	136.95	103.87	123.80	151.46
Operating Profit After Depreciation	190.92	205.88	146.87	172.85	211.97

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	678.69	660.11	654.94	624.55	606.13
Total Non Current Assets	741.48	725.72	699.74	663.17	636.61
Total Current Assets	879.87	809.74	722.11	604.44	516.07
Total Assets	1,621.35	1,535.46	1,421.85	1,267.61	1,152.67
Total Shareholder's Fund	1,420.86	1,324.13	1,235.07	1,088.59	970.66

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	142.50	141.37	140.36	122.29	162.89
Net Cash Used In Investing Activities	-89.48	-64.80	-285.50	1.65	-27.33
Net Cash Used In Financing Activities	-72.54	-59.24	-25.80	-48.50	-26.31

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	412.90	424.28	321.34	281.88	290.30
Total Expenses	292.37	271.34	247.06	209.81	191.87
Profit Before Tax	120.53	133.99	74.28	72.07	98.43
Profit After Tax	102.42	108.12	55.53	54.51	71.01
Operating Profit After Depreciation	120.76	153.10	74.41	72.17	98.53

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	156.52	147.54	148.28	137.46	137.60
Total Non Current Assets	456.43	384.59	386.26	352.94	329.37
Total Current Assets	232.20	248.34	189.54	176.69	160.23
Total Assets	688.63	632.93	575.80	529.62	489.60
Total Shareholder's Fund	629.34	580.47	525.33	480.35	435.45

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	63.48	51.63	50.30	37.10	84.19
Net Cash Used In Investing Activities	-1.74	-2.70	-42.35	-14.24	-69.91
Net Cash Used In Financing Activities	-57.63	-56.88	-11.99	-10.87	-15.45

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	203.37	171.95	184.53	185.91	167.18
Total Expenses	140.14	122.60	124.47	129.48	121.57
Profit Before Tax	59.81	58.29	59.54	54.90	43.47
Profit After Tax	45.25	43.18	44.73	40.44	26.73
Operating Profit after Depreciation	70.46	57.82	70.34	65.28	54.36

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	116.41	95.58	115.75	125.02	87.21
Total Expenses	89.55	72.12	86.16	94.50	73.04
Profit Before Tax	28.84	17.80	29.62	81.39	15.51
Profit After Tax	22.30	13.25	22.28	73.98	11.05
Operating Profit after Depreciation	32.02	24.75	32.67	84.37	18.70

Advanced Enzyme Technologies Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 356.63

S2 351.87

S3 345.63

Pivot 362.87

R1 367.63

R2 373.87

R3 378.63

Moving Average

20 SMA 374.55

50 SMA 339.45

100 SMA 313.82

200 SMA 315.54

Advanced Enzyme Technologies Ltd Corporate Actions

Advanced Enzyme Technologies Ltd

₹1.2/Share

Announcement Date 23 Jul 2025

Record Date 23 Jul 2025

Div Yield 60%

AGM Date: 08 Sep 2021

This is to inform that the 32nd Annual General Meeting (AGM) of the Company will be held on Wednesday September 08 2021 through Video Conference / Other Audio Visual Means (VC/OAVM). Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in furtherance to our letter dated May 29, 2021 intimating that the dividend of Rs. 0.90 per Equity Share of Rs. 2 each for the financial year 2020-21 ('FY21') recommended by the Board of Directors of the Company, it is hereby informed that Record Date has been fixed as Wednesday, September 01, 2021, for the purpose of ascertaining the entitlement of the Members to the said final dividend for FY21, if approved (declared) at the 32nd AGM. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (as amended) read with Schedule III of the SEBI Listing Regulations, and in furtherance to our letter dated August 10, 2021 intimating about the 32nd Annual General Meeting of the Company ('AGM'), please find enclosed the Notice of 32nd AGM of the Company scheduled to be held on Wednesday, September 08, 2021 at 10:00 a.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM'), which is also sent by electronic mode to the Members of the Company. The aforesaid Notice of 32nd AGM is also uploaded on the website of the Company (As Per BSE Announcement Dated on 16.08.2021) Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('LODR') read with Part A of the Schedule III to the SEBI LODR, please find enclosed the summary of the proceedings of 32nd Annual General Meeting of the Company held on Wednesday, September 08, 2021 through Video Conference ('VC') or Other Audio Visual Means ('OAVM'). (As Per BSE Announcement dated on 09.09.2021)

AGM Date: 19 Aug 2022

AGM 19/08/2022 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') (as amended) read with Schedule III of the SEBI Listing Regulations, and in furtherance to our letter dated July 21, 2022 intimating about the 33rd Annual General Meeting of the Company ('AGM'), please find enclosed the Notice of 33rd AGM of the Company scheduled to be held on Friday, August 19, 2022 at 10:00 a.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM'), which is also being sent by electronic mode to the Members of the Company. The aforesaid Notice of 33rd AGM is also uploaded on the website of the Company (As Per BSE Announcement Dated on 27.07.2022) CORRIGENDUM - NOTICE OF THE 33RD ANNUAL GENERAL MEETING OF ADVANCED ENZYME TECHNOLOGIES LIMITED (As Per BSE Announcement Dated on 30/07/2022) Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 details regarding the voting results, based on the Scrutinizers report dated August 19, 2022 is enclosed. Also, Consolidated Scrutinizer Report dated August 19, 2022 on remote e-voting and electronic voting during the AGM is enclosed. Advanced Enzyme Technologies Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 20.08.2022)

AGM Date: 12 Aug 2023

Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 , it is hereby informed that Record Date has been fixed as Saturday, August 05, 2023, for the purpose of ascertaining the entitlement of the Members to the final dividend for FY 2023, if approved(declared) at the 34th AGM 34th Annual General Meeting of the Company will be held on Saturday, August 12, 2023, through Video Conference/ Other Audio Visual Means ( VC/OAVM) Notice of 34th AGM of the Company Scheduled to be held on Saturday, August 12, 2023 at 3:00 p.m. (IST) through Video Conference ('VC') or Other Audio Visual Means ('OAVM') (As Per BSE Announcement dated on 13.07.2023) Newspaper Publication informing the members inter-alia regarding the 34th AGM of the Company, Annual Report for financial year 2022-23 and the AGM notice sent by electronic mode(email). (As Per BSE Announcement Dated on 14.07.2023) Proceedings of 34th Annual General Meeting held on August 12, 2023. (As per BSE Announcement Dated on 12/08/2023)

AGM Date: 25 Jul 2024

This is to inform that the 35th Annual General Meeting of the Company will be held on Thursday, July 25, 2024. Record Date has been fixed as Thursday July 18, 2024 for the purpose of ascertaining the entitlement of the members to the Final Dividend for FY24, if approved (declared) at the 35th AGM. Notice of 35th Annual General Meeting of the Company (As Per BSE Announcement dated on 01.07.2024) Proceedings of 35th Annual General Meeting (AGM) held on July 25, 2024 Consolidated report of the Scrutinizer and details regarding voting results of 35th Annual General Meeting of the Company held on July 25, 2024 (As Per BSE Announcement Dated on: 25/07/2024)

AGM Date: 30 Jul 2025

The 36 th Annual general Meeting of the Company will be held on July 30 , 2025 Please find enclosed herewith Notice of the 36th Annual General Meeting of the Company. (As Per BSE Announcement dated on 03.07.2025) Please find enclosed herewith copies of Newspaper publication with respect to the completion of dispatch of Notice and Integrated Annual report for FY 2024-2025. (As Per BSE Announcement Dated on: 04.07.2025) Proceedings of the 36th Annual General Meeting (AGM) held on July 30, 2025. (As Per BSE Announcement Dated on: 30/07/2025)

Advanced Enzyme Technologies Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Advanced Enzyme Technologies Ltd Top Mutal Funds Invested

Fund Name	AUM
ICICI Pru ESG Exclusionary Strategy Fund	2.22%
UTI-MNC Fund	1.41%
Motilal Oswal Nifty Microcap 250 Index Fund	0.21%
Bandhan BSE Healthcare Index Fund	0.12%
Bank of India ELSS Tax Saver	0.10%

Advanced Enzyme Technologies Ltd News

Advanced Enzyme Technologies announces cessation of director

With effect from 11 June 2026

11 Jun 2026, 04:41 pm

Board of Advanced Enzyme Techs. recommends final dividend

Of Rs 1.35 per share

09 May 2026, 04:15 pm

Advanced Enzyme Techs. to hold board meeting

On 9 May 2026

04 May 2026, 10:26 am

Advanced Enzyme Technologies receives ratings action from ICRA

13 Feb 2026, 03:02 pm

Advanced Enzyme Techs. to hold board meeting

On 31 January 2026

24 Jan 2026, 09:54 am

Advanced Enzyme Technologies Ltd Stock Analysis

Annual revenue for Advanced Enzyme Technologies Ltd decreased by 2.68% to ₹412.90 crore in FY 2025 from ₹424.28 crore in FY 2024.
Annual Net Profit for Advanced Enzyme Technologies Ltd decreased by 5.27% to ₹102.42 crore in FY 2025 from ₹108.12 crore in FY 2024.
Promoter Shareholding in Advanced Enzyme Technologies Ltd increased by 0.51% in the most recent quarter, from 43.04% in December 2025 to 43.26% in March 2026.
Advanced Enzyme Technologies Ltd delivered a 1-year return of 8.61% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Advanced Enzyme Technologies Ltd share price moved up by 2.17% from its previous close of INR ₹361.40. The latest Advanced Enzyme Technologies Ltd share price is INR ₹369.25.
Advanced Enzyme Technologies Ltd share price today has been at a low of 362.50 and a high of 369.95. Over the past 52 weeks, the Advanced Enzyme Technologies Ltd share price has seen a low of 251.95 and a high of 419.